(Q46196780)

20 December 2017

title

Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria (English)

1 reference

20 December 2017

author name string

Kong-Sang Wan

series ordinal

1

1 reference

20 December 2017

language of work or name

1 reference

1 January 2009

1 reference

20 December 2017

Journal of Dermatological Treatment

published in

1 reference

20 December 2017

volume

20

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

page(s)

194-197

1 reference

20 December 2017

Clinical practice. Chronic urticaria and angioedema

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09546630802607495

Effect of omalizumab on patients with chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802607495

Chronic urticaria: aetiology, management and current and future treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802607495

Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802607495

Significant association of FcepsilonRIalpha promoter polymorphisms with aspirin-intolerant chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802607495

Chronic idiopathic urticaria treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802607495

Human skin mast cells express H2 and H4, but not H3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802607495

The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802607495

Montelukast treatment of urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802607495

Chronic urticaria: pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802607495

Basophil histamine release activity and disease severity in chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802607495

Montelukast in allergic diseases beyond asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802607495

Antihistamines in the pediatric population: achieving optimal outcomes when treating seasonal allergic rhinitis and chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802607495

Levocetirizine: The latest treatment option for allergic rhinitis and chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802607495

Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802607495

Chronic idiopathic urticaria: Comparison of the clinical features of patients with and without anti-FcϵRI or anti-IgE autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802607495

10.1080/09546630802607495

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

19085267

1 reference

20 December 2017